| Product NDC: | 53808-0408 |
| Proprietary Name: | Glipizide XL |
| Non Proprietary Name: | glipizide |
| Active Ingredient(s): | 10 mg/1 & nbsp; glipizide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 53808-0408 |
| Labeler Name: | State of Florida DOH Central Pharmacy |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020329 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090701 |
| Package NDC: | 53808-0408-1 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (53808-0408-1) |
| NDC Code | 53808-0408-1 |
| Proprietary Name | Glipizide XL |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (53808-0408-1) |
| Product NDC | 53808-0408 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | glipizide |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20090701 |
| Marketing Category Name | NDA |
| Labeler Name | State of Florida DOH Central Pharmacy |
| Substance Name | GLIPIZIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |